Formuepleje A/S’s Teladoc Health TDOC Stock Holding History

Formuepleje A/S’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,925	Closed	-$329K	–	91
2019 Q4	$329K	Buy	3,925 +45	+1%	+$3.42K	0.02%	69
2019 Q3	$263K	Buy	+3,880	New	+$255K	0.02%	81

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Formuepleje A/S's TDOC Position: Q1 2020 in Review

Formuepleje A/S sold out of Teladoc Health (TDOC) in Q1 2020, closing a stake of 3,925 shares — an estimated $329K sold.

Formuepleje A/S first reported a position in TDOC in Q3 2019 and held it in 2 quarters. The position peaked at $329K in Q4 2019. 578 funds tracked by Wall St. Rank hold TDOC as of Q1 2020.

Formuepleje A/S reported no remaining Teladoc Health position as of Q1 2020 after selling out during the quarter.
Formuepleje A/S sold 3,925 Teladoc Health shares in Q1 2020, an estimated $329K.
Formuepleje A/S first reported a position in Teladoc Health in Q3 2019 and held it in 2 quarters.
Formuepleje A/S's Teladoc Health position peaked at $329K in Q4 2019.
578 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2020.

Based on Formuepleje A/S's 13F filing for Q1 2020, filed 27 Aug 2026.